Teva Pharmaceutical’s $2.1 Billion Bond Offering

Baker McKenzie and Herzog, Fox & Neeman advised the syndicate of 14 initial purchasers on the deal. The offering consisted of USD 2.1 billion (equivalent) dual-tranche…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here